In the last trading session, 1.56 million CARGO Therapeutics Inc (NASDAQ:CRGX) shares changed hands as the company’s beta touched 0.73. With the company’s per share price at $3.80 changed hands at -$0.31 or -7.54% during last session, the market valuation stood at $175.00M. CRGX’s last price was a discount, traded about -762.89% off its 52-week high of $32.79. The share price had its 52-week low at $3.00, which suggests the last value was 21.05% up since then. When we look at CARGO Therapeutics Inc’s average trading volume, we note the 10-day average is 0.61 million shares, with the 3-month average coming to 992.55K.
Analysts gave the CARGO Therapeutics Inc (CRGX) stock a consensus recommendation rating of Buy, calculated at a mean rating of 3.25. If we narrow down to specifics, the data shows that 0 out of 2 analysts rate the stock as a Sell, with a further 0 assigning it an Overweight rating. Of the remaining, 0 recommended CRGX as a Hold, 2 felt it is a Buy and 0 rated the stock as Underweight. CARGO Therapeutics Inc’s EPS for the current quarter is expected to be -0.57.
CARGO Therapeutics Inc (NASDAQ:CRGX) trade information
Instantly CRGX was in red as seen at the end of in last trading. With action -3.06%, the performance over the past five days has been red. The company’s shares are showing year-to-date downside of -73.65%, with the 5-day performance at -3.06% in the red. However, in the 30-day time frame, CARGO Therapeutics Inc (NASDAQ:CRGX) is 2.70% up. Looking at the short shares, we see there were 3.39 million shares sold at short interest cover period of 1.69 days.
The consensus price target for the stock as assigned by Wall Street analysts is 7, meaning bulls need an upside of 45.71% from its current market value. According to analyst projections, CRGX’s forecast low is 7 with 7 as the target high. To hit the forecast high, the stock’s price needs a -84.21% plunge from its current level, while the stock would need to soar -84.21% for it to hit the projected low.
According to analysts, the company will likely register a growth in its current quarter sales, forecast at 0.00%. The estimates for the next quarter sales put growth at 0.00%.
The 2025 estimates are for CARGO Therapeutics Inc earnings to increase by 78.21%, but the outlook for the next 5-year period is at 48.00% per year.
CRGX Dividends
CARGO Therapeutics Inc is expected to release its next quarterly earnings report on 2025-Mar-11.
CARGO Therapeutics Inc (NASDAQ:CRGX)’s Major holders
If we look at who the major shareholders are, we find that insiders hold 0.24% of CARGO Therapeutics Inc shares while 122.58% of the shares are in the hands of institutional holders. The share float percentage for the stock currently stands at 122.88%. There are 122.58% institutions holding the CARGO Therapeutics Inc stock share, with FMR LLC the top institutional holder. As of 2024-06-30, the company held 15.8659% of the shares, roughly 6.88 million CRGX shares worth $112.92 million.
SAMSARA BIOCAPITAL, LLC holds the second largest percentage of outstanding shares, with 10.1875% or 4.42 million shares worth $72.51 million as of 2024-06-30.
Among Mutual Funds, the top two as of Dec 31, 2024 were Vanguard Total Stock Market Index Fund and Price (T.Rowe) Health Sciences Fund . With 1.19 shares estimated at $4.53 million under it, the former controlled 2.59% of total outstanding shares. On the other hand, Price (T.Rowe) Health Sciences Fund held about 2.48% of the shares, roughly 1.14 shares worth around $4.33 million.
